BridgeBio Pharma Q2 EPS $(0.98) Misses $(0.83) Estimate, Sales $1.64M Miss $2.99M Estimate
Portfolio Pulse from Happy Mohamed
BridgeBio Pharma reported Q2 losses of $(0.98) per share, missing the analyst consensus estimate of $(0.83) by 18.07%. The company's quarterly sales were $1.64 million, missing the estimate of $2.99 million by 45.12%. This represents a 97.77% decrease over sales from the same period last year.
August 04, 2023 | 1:04 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BridgeBio Pharma's Q2 earnings and sales missed estimates, indicating a potential negative impact on the stock.
BridgeBio Pharma's Q2 earnings and sales fell short of analyst estimates, which could lead to a decrease in investor confidence and a potential drop in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100